IL1R1 and triple-A syndrome: Farhang et al. have demonstrated that repression of TNFR1 and IL1R1 could inhibit NF-κB activation, promote extracellular matrix (ECM) deposition, and allow for maintenance of immunomodulatory properties in inflammatory conditions, which was similar to the pathology of AAA [34].